Abstract:Background: Recent studies have demonstrated the significance of the DEAD-box helicase 5 (DDX5) gene, which is involved in pathways concerning the modification of RNA structures. DDX5 functions as a coregulator of cellular transcription and splicing, and participates in the processing of small noncoding RNAs. The aberrant regulation of DDX5 expression possibly plays a significant role in the genesis of cancer. However, there are no comprehensive pan-cancer studies on DDX5. This study is the first to conduct a pan-cancer analysis of DDX5 for aiding the diagnosis and treatment of cancer.Methods: The gene expression, genetic alterations, protein phosphorylation, promoter methylation, immune infiltration, and enrichment analyses of DDX5 were performed using data retrieved from The Cancer Genome Atlas (TCGA), Genotype-tissue Expression (GTEx), Human Protein Atlas (HPA), Tumor Immunological Estimation Resource 2.0 (TIMER2.0), Gene Expression Profiling Interactive Analysis (GEPIA), DNA methylation interactive visualization database (DNMIVD), and Search Tool for the Retrieval of Interaction Genes/Proteins (STRING). Data analyses were performed with the R software and other webtools.Results: The expression of DDX5 mRNA decreased significantly in 17 cancer types, but increased significantly in eight cancer types. The enhanced expression of DDX5 mRNA in the tumor samples was related to decreased overall survival (OS), progression-free interval (PFI), and disease-specific survival (DSS) in three cancers, but increased OS, PFI, and DSS in other cancers. The DNA promoter methylation level was significantly reduced in eight cancer types, and there were exceptions in the methylation levels of the DDX5 promoter in four cancer types. The expression of DDX5 mRNA was highly correlated with the infiltration of CD8+ T cells, cancer-associated fibroblasts, and B cells in a wide variety of malignancies. The findings revealed a strong association between DDX5 and its co-expressed genes in numerous cancer types. Enrichment analysis suggested that DDX5 was associated with multiple cellular pathways, including RNA splicing, Notch signaling pathway, and viral carcinogenesis, which was consistent with the results of previous studies.Conclusion: The findings obtained herein provide further information on the oncogenic potential of DDX5 in diverse tumor types. We propose that DDX5 has important roles in tumor immunity and the diagnosis of cancer.

Genomic analyses identify significant biological processes in DDX21-mediated colorectal cancer cells

Delineating the Underlying Molecular Mechanisms and Key Genes Involved in Metastasis of Colorectal Cancer Via Bioinformatics Analysis

DDX10 promotes the proliferation and metastasis of colorectal cancer cells via splicing RPL35

DDX21 Interacts with WDR5 to Promote Colorectal Cancer Cell Proliferation by Activating CDK1 Expression

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types

Application of RNA Processing Factors for Predicting Clinical Outcomes in Colon Cancer.

Identification of Key Genes in Colorectal Cancer Using Random Walk with Restart

DDX10 Promotes the Proliferation and Metastasis of CRC Cells Via RPL35

Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer

Pan-cancer analysis identifies RNA helicase DDX1 as a prognostic marker

DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1

Identification of key pathways and genes in colorectal cancer using bioinformatics analysis

CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis

ANLN, COL8A1, MMP3, MMP14 and WNT5A, As Potential Diagnostic and Therapeutic Targets for Early-Stage Colorectal Cancer: Evidence from Integrated Bioinformatics Analysis

DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway

Navigating colorectal cancer prognosis: A Treg‐related signature discovered through single‐cell and bulk transcriptomic approaches

Pan-cancer Analysis of the Prognostic and Immunological Roles of DEAD-box Helicase 5 (DDX5) in Human Tumors

Microarray analysis of differentially-expressed genes and linker genes associated with the molecular mechanism of colorectal cancer

ATG10-dependent autophagy is required for DDX10 to regulate cell proliferation, apoptosis and stemness in colorectal cancer

Comprehensive Analysis Reveals A Four-Gene Signature In Colorectal Cancer

Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis